MM2 Group's Diet Product Featured on CW Network
Local News in New York City

Sugarest™ Gum Provides "Instant Will Power" to Avoid Sugar and Sweets

Livingston, NJ, February 23, 2007 - MM2 Group, Inc. (OTCBB: MMGP) announced today that Sugarest™, the diet gum created by its wholly-owned subsidiary, Genotec Nutritionals, Inc., was featured in a news story broadcast on the CW Network's Channel 11 in New York City. The broadcast was seen throughout the entire New York tri-state area.

The story, which was shown as on the news hour's regular "Remedy or Rip-Off" segment, is now posted on the CW11 website. To read the story and view the video, please go to http://cw11.empowereddoctor.com.

Sugarest™ is a minty tablet which dissolves in your mouth and temporarily blocks and neutralizes the sweet-taste receptors of your taste buds. Simply place a tablet in your mouth for 2 minutes, and sugary foods and sweets lose their taste and appeal, giving a dieter the "instant will power" they need to keep to their diet. The effect lasts for 20-30 minutes, long enough for a dieter to defeat ther sugar cravings and lose their desire for sweet but fattening foods. Additional information may be found on the Sugarest™ website at www.sugarest.com.

George Kontonotas, President of Genotec Nutritionals, stated, "We are overwhelmed at the amazingly positive response Sugarest™ has received. Orders are rapidly coming in, and we have been contacted by other television stations about dong more stories on the product. We are very excited about the future for the product and for the company."

Mark Meller, CEO of MM2 Group, said, "The response to Sugarest™ has been so great that we will need to go back and begin manufacturing additional product immediately. Sugarest™ is on its way to becoming a tremendous success, and we have additional products being introduced in the next several months. We anticipate making several more exciting announcements in the very near future."

About MM2 Group, Inc.
MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at (732) 290-0019 or by e-mail at meller@mm2group.net or Jerry Mahoney at jerrym@mm2group.net.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.